Why the study?
Does emergent biventricular assist device placement eliminate refractory polymorphic ventricular tachycardia in a patient with giant cell myocarditis?
Does emergent biventricular assist device placement eliminate refractory polymorphic ventricular tachycardia in a patient with giant cell myocarditis?
Biventricular assist device placement may be an effective emergent intervention for terminating refractory polymorphic ventricular tachycardia in patients with giant cell myocarditis.
Answers are grounded in this paper and cite their sources.
May support biventricular assist device consideration for refractory polymorphic VT in giant cell myocarditis; leaves open need for prospective validation.
We present the case of a 55-year-old woman with giant cell myocarditis who experienced a rapid deterioration in her condition. As her heart failure progressed, she developed more ventricular ectopic beats, which culminated in a polymorphic ventricular tachycardia that did not improve despite immunosuppressive and antiarrhythmic therapy. Emergent biventricular assist device placement, however, did eliminate her arrhythmia.
No takes yet. Share an insight, caveat, or question.
A 2020 study studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: